Maria Salvadó Figueras Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders. Instituciones de las que forman parte Investigador postdoctoral Sistema Nervioso Periférico Vall Hebron Institut de Recerca Neurología Hospital General Email Maria Salvadó Figueras Email Instituciones de las que forman parte Investigador postdoctoral Sistema Nervioso Periférico Vall Hebron Institut de Recerca Neurología Hospital General Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders.
She works as a neurologist at the Neuromuscular and Rare Diseases Unit of Vall d'Hebron Hospital and as a researcher in the Peripheral Nervous System Disease Research Laboratory (VHIR), currently led by Dr. R. Juntas-Morales. The main lines of this research group are based on the identification of new biomarkers and genetic determinants in familial and sporadic forms of amyotrophic lateral sclerosis (ALS), autoimmune myasthenia gravis (MG), and genetic-based myopathies and neuropathies. She is also one of the professionals in the European Network for Neuromuscular and Rare Diseases (EURO-NMD ERN) and the European Network for rare neurological diseases (ERN-RND). Hospital Vall d’Hebron is member of these ERNs. She is co-author of more than 20 peer-reviewed articles and in February 2020, she obtained her PhD title from the Autonomous University of Barcelona for her thesis entitled "Study of genetic factors that influence the familial and sporadic forms of myasthenia gravis autoimmune ”(Teseo, TDX). In 2013, she was awarded the Scientific Poster Award at the International Symposium for ALS (MNDA). She is a co-investigator for several grants, research projects and clinical trials, including FIS (Fondo de Investigación Sanitarias) and MINECO (Ministerio de Economía y Competitividad) grants. These grants are for studies of rare neurological diseases such as ALS, myasthenia gravis, familial amyloid polyneuropathy (Corino-Andrade disease), mitochondrial diseases and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Proyectos ANÁLISIS DE FACTORES GENETICOS DE SUSCEPTIBILIDAD Y MODIFICANTES DE FENOTIPO EN LAS FORMAS FAMILIARES Y ESPORADICAS DE MIASTENIA GRAVIS AUTOIMMUNE MEDIANTE TECNICAS DE SECUENCIACIÓN MASIVA IP: Josep Gamez Carbonell Colaboradores: Gisela Gili Serrat, Maria Salvadó Figueras, Francesc Rudilla Salvador Entidad financiadora: Instituto de Salud Carlos III Financiación: 92565 Referencia: PI16/01673 Duración: 01/01/2017 - 05/06/2020 Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis.(ITL) Codi Protocol: MG2012PREP IP: Josep Gamez Carbonell Colaboradores: Maria Salvadó Figueras Entidad financiadora: CSL Behring LLC "CSL" Financiación: 176819.76 Referencia: ITL_CSL-ILA2011 Duración: 26/07/2012 - 31/12/2016 Estudio mutacional del gen TARDBP en las formas familiar y esporádica de ELA. Análisis de la expresión en plasma y LCR de la proteína TDP-43 como biomarcadores de la enfermedad y de su correlación con los hallazgos neuropatológicos IP: Josep Gamez Carbonell Colaboradores: Maria Salvadó Figueras, Oriol de Fabregues-Boixar Nebot Entidad financiadora: Instituto de Salud Carlos III Financiación: 80465 Referencia: PI10/01970 Duración: 01/01/2011 - 30/06/2014 Paginación Primera página « Página anterior ‹ Página 1 Página actual 2
